Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,767 | 55,103 | 59,197 | 56,060 | 78,672 |
| Marketable Securities | 242,187 | 259,932 | 284,603 | 334,561 | 393,165 |
| Receivables | 30,616 | 32,257 | 31,645 | 27,524 | 29,383 |
| Inventories | 53,153 | 53,839 | 54,007 | 58,755 | 65,737 |
| TOTAL | $394,236 | $413,397 | $444,923 | $495,681 | $584,234 |
| Non-Current Assets | |||||
| PPE Net | 22,127 | 23,102 | 24,794 | 30,505 | 31,952 |
| Intangibles | 333,904 | 334,924 | 335,943 | 707,333 | 805,487 |
| Other Non-Current Assets | 52,891 | 54,047 | 55,129 | 26,928 | 28,379 |
| TOTAL | $408,922 | $412,073 | $415,866 | $764,766 | $865,818 |
| Total Assets | $803,158 | $825,470 | $860,789 | $1,260,447 | $1,450,052 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,362 | 15,055 | 14,037 | 16,590 | 12,064 |
| Accrued Expenses | 29,172 | 26,541 | 29,337 | 22,595 | 19,183 |
| Other current liabilities | 1,005 | 2,592 | 5,570 | 3,224 | 783 |
| TOTAL | $63,209 | $59,754 | $66,602 | $66,299 | $59,997 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 16,049 | 14,863 | 15,241 | 13,864 | 17,292 |
| Other Non-Current Liabilities | 699,459 | 698,518 | 696,694 | 681,654 | 931,478 |
| TOTAL | $703,859 | $704,227 | $702,549 | $687,554 | $936,933 |
| Total Liabilities | $767,068 | $763,981 | $769,151 | $753,853 | $996,930 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 301,907 | 300,371 | 300,085 | 297,852 | 273,864 |
| Common Shares | 302 | 300 | 300 | 294 | 274 |
| Retained earnings | -2,654,931 | -2,616,931 | -2,575,001 | -2,148,926 | -2,151,297 |
| Other shareholders' equity | 415 | 267 | 381 | 422 | 1,553 |
| TOTAL | $36,090 | $61,489 | $91,638 | $506,594 | $453,122 |
| Total Liabilities And Equity | $803,158 | $825,470 | $860,789 | $1,260,447 | $1,450,052 |